- Report
- January 2023
- 192 Pages
Global
From €4759EUR$4,950USD£4,076GBP
- Report
- April 2023
- 111 Pages
Global
From €4110EUR$4,275USD£3,520GBP
€4567EUR$4,750USD£3,911GBP
- Report
- April 2023
- 307 Pages
Global
From €4759EUR$4,950USD£4,076GBP
- Report
- September 2022
- 274 Pages
Global
From €4413EUR$4,590USD£3,779GBP
- Report
- May 2023
- 249 Pages
Global
From €3417EUR$3,554USD£2,926GBP
€3797EUR$3,949USD£3,251GBP
- Report
- February 2020
- 105 Pages
Global
From €3605EUR$3,750USD£3,088GBP
- Report
- August 2022
- 91 Pages
Global
From €3500EUR$3,900USD£3,102GBP
The qPCR Reagent market is a subset of the biotechnology industry, focusing on the production and sale of reagents used in quantitative polymerase chain reaction (qPCR) tests. qPCR is a laboratory technique used to detect and quantify the presence of specific DNA or RNA sequences in a sample. qPCR reagents are used to amplify and detect these sequences, and are essential for the accurate and reliable performance of qPCR tests.
The qPCR Reagent market is highly competitive, with a range of companies offering products for different applications. Companies in the market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Takara Bio, and QIAGEN. Show Less Read more